Alibaba is a buy, this portfolio manager says

Darren Sissons
Shareholders of Alibaba (Alibaba Stock Quote, Chart NYSE:BABA) weren’t too pleased with the stock’s performance last fall, but the start to 2019 has been a different story. Is there more upside? Portfolio manager Darren Sissons says likely.

“It had a big sell-off over the fourth quarter but for those with higher risk appetites, you can buy it here. We have some in our system but it’s definitely not broadly held,” says Sissons of Campbell Lee & Ross to BNN Bloomberg last Thursday.

“Alibaba is effectively what started out as a logistics play for product online, because if you’ve ever been to China the population density is such that you need to get things delivered because you can’t go and drive two hours to go get them — it just doesn’t make sense,” he says. “The business is definitely flourishing and innovative and they’ve added different businesses on to make more money.”

Ahead of the company’s quarterly earnings due on May 15, Alibaba’s stock jumped in late January as the market responded to its fiscal third quarter, although revenues grew at their slowest pace in three years in response to a cooling Chinese economy. The e-commerce giant posted Q3 revenue of 117.28 billion yuan (or US$17.47 billion), which compared with 83 billion yuan a year earlier and stood close to analysts’ forecasts for 118.9 billion yuan. Net income of 30.96 billion yuan beat the Street’s estimate and showed year-over-year growth of 33 per cent.

Analysts have noted management’s more controlled spending as of late, even as the company spent a record 278.8 billion yuan or $41.6 billion in 2018 on product development, sales and marketing and general administration.

Alibaba’s share price grew by close to 150 per cent between mid-2015 and June of last year, when the stock reached a high of US$211.70. From there, the drop-off was steep, however, with BABA losing almost 40 per cent of its value before starting to turn things around in late December. Currently, the stock is up 37 per cent year-to-date.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: baba
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Héroux-Devtek is a buy, Desjardins says

Ahead of the company's quarterly results, Desjardins Securities analyst Benoit Poirier likes what he sees from Héroux-Devtek (Héroux-Devtek Stock Quote,… [Read More]

11 mins ago

JUSH stock is a buy, Beacon says

With its first quarter results on deck, Beacon Securities analyst Russell Stanley thinks Jushi Holdings (Jushi Holdings Stock Quote, Chart,… [Read More]

19 hours ago

Is Curaleaf stock still a buy?

The stock has been a steady climber since last October, but ahead of earnings is Curaleaf (Curaleaf Stock Quote, Chart,… [Read More]

21 hours ago

OpenText price target cut at National Bank

Following third quarter results he describes as "in-line", National Bank Financial analyst Richard Tse has cut his price target on… [Read More]

22 hours ago

Silicon Motion stock still a buy, Roth says

Following the company's first quarter results, Roth MKM analyst Suji Desilava remains bullish on Silicon Motion Technology (Silicon Motion Technology… [Read More]

23 hours ago

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

4 days ago